Private label famotidine
This article was originally published in The Tan Sheet
Executive Summary
Cheminor Drugs receives tentative approval from FDA Dec. 13 for OTC famotidine 10 mg tablets (ANDA 75-758). Reference drug is J&J/Merck's Pepcid AC, which recently was granted additional six months of exclusivity based on pediatric data submitted by firm, postponing market entry of generic versions of H2 antagonist until April 15. Both Teva Pharmaceuticals and Danbury Pharmacal also have tentative approvals; Perrigo, PFI, Leiner and Zenith Goldline intend to offer generic famotidine in 2001 (1"The Tan Sheet" Nov. 27, p. 11)